new method of Trans-urethral resection of the prostate will be tested on different patients prostate cancer stages: Stage 1 (100 patients), Stage 2 (90 patients), Stage 8 (10 patients), Stage 7 (15 patients), Stage 0 (200 patients), Stage 3 (85 patients), Stage 5 (80 patients), Stage 4 (70 patients), Stage 6 (68 patients). Benefits per patient are the following: Stage 0: 10 Stage 1: 20 Stage 3: 40 Stage 4: 50 Stage 5: 60 Stage 6: 80 Stage 7: 90 Stage 8: 100 Compute cumulative benefits per stage Compute cumulative patients per stage Graph the cumulative benefits curve Which variable represents marginal benefits per stage? Compute the average benefits per stage Why is the average benefits less reliable than marginal benefits as an indicator of additional benefits if the treatment is expanded to less sick individuals?